Effect of Dexamethasone on Duration of Lower Extremity Blocks With Bupivacaine in Subjects Having ACL Repair

Duration of Pain Relief Clinical Trial

Official title:

A Study of the Effect of Dexamethasone on Duration of Lower Extremity Blocks With Bupivacaine in Subjects Having ACL Repair

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT01756560
• Other study ID #: IRB12-2191
• Status: Terminated
• Phase: Phase 4
• Start date: January 2013
• Est. completion date: January 2015

Study information

• Verified date: April 2019
• Source: University of Chicago
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Anterior cruciate ligament reapair is a painful procedure. Single shot femoral and sciatic nerve block only last 12-16 hrs. Since dexamethasone prolongs brachial plexus block, using it in lower extremity blocks will prolong the analgesia to provide better outpatient pain relief after surgery at home.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 2
• Est. completion date: January 2015
• Est. primary completion date: January 2015
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• age 18-75, no contraindication to regional anesthesia

Exclusion Criteria:

• peripheral neuropathy

Related Conditions & MeSH terms

• Duration of Pain Relief

Intervention

Drug:
• dexamethsone

• Bupivacaine

Locations

Country	Name	City	State
United States	University of Chicago Medical Center	Chicago	Illinois

Sponsors (1)

Lead Sponsor	Collaborator
University of Chicago

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Analgesia Duration		72 hours